-
Innovation Ranking
NewInnovation Ranking – SS&C Technologies Holdings Inc.
SS&C Technologies Holdings Inc (SS&C) is a provider of software and related services to financial services and the healthcare industry. The company provides software solutions for multinational banks, commercial lenders, health insurance companies, private equity funds, brokers/dealers, commercial lenders, corporate treasury groups, municipal finance groups, insurance and pension funds and real estate lenders and property managers. These products allow financial services providers to automate complex business processes and effectively manage information-processing requirements. It also offers several services, including fund administration,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SS-0350 in Bacterial Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SS-0350 in Bacterial Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SS-0350 in Bacterial Infections Drug Details: SS-0350 is under development for the...
-
Product Insights
SS-Xavier I Project
The SS-Xavier I Project is a iron ore mine in Chile. It is currently in operation. Empower your strategies with our SS-Xavier I Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Analyst Opinions
NewMobile World Congress (MWC) 2024 – Startups Race for Digital Change
Mobile World Congress (MWC) 2024 Report Overview MWC (Mobile World Congress) is a premier global event for the mobile technology industry, while 4YFN (4 Years from Now) is its associated platform focusing on connecting startups with investors and partners to drive innovation. With over 40 companies in attendance, AI startups took center stage at MWC 2024, signaling robust investor and market interest in AI as the key driver for future innovation. Beyond AI, fintech, digitalization, IoT, digital media, and health...
-
Thematic Analysis
NewApplication Software Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Companies scoring well in the artificial intelligence (AI), big data, and cloud computing-related themes lead the thematic screen of GlobalData’s application software sector scorecard. This screen is dominated by the large US cloud vendors (Microsoft, Amazon, and Alphabet), but also includes leading enterprise software companies such as IBM, SAP, and Infor, as well as Apple. There have been minor score changes for companies such as Broadcom, OpenText, and Software AG due to their divestitures following recent acquisitions.
-
Company Insights
Innovation and Patenting activity of SS&C Technologies Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of SS&C Technologies Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Analyst Opinions
NewWheels of Change – Startups Revolutionizing Mobility
Startups Revolutionizing Mobility Market Report Overview Technological innovations, evolving policies, and changing consumer preferences are driving the adoption of new mobility trends that are sustainable, smart, and flexible. The mobility sector is embracing advanced technologies and experiencing increased partnerships, investments, and government support. The ‘Wheels of Change: Startups Revolutionizing Mobility Market’ research provides valuable insights into innovative startups across 14 emerging trends in mobility. The report thoroughly examines the latest advancements, unique offerings, and venture capital activities of these startups,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Golidocitinib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golidocitinib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golidocitinib in Non-Small Cell Lung Cancer Drug Details: Golidocitinib (DZD-4205)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golidocitinib in Cutaneous T-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golidocitinib in Cutaneous T-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golidocitinib in Cutaneous T-Cell Lymphoma Drug Details: Golidocitinib (DZD-4205) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golidocitinib in Sezary Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golidocitinib in Sezary Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golidocitinib in Sezary Syndrome Drug Details: Golidocitinib (DZD-4205) is under development for...